Your browser doesn't support javascript.
loading
Melanoma models for the next generation of therapies.
Patton, E Elizabeth; Mueller, Kristen L; Adams, David J; Anandasabapathy, Niroshana; Aplin, Andrew E; Bertolotto, Corine; Bosenberg, Marcus; Ceol, Craig J; Burd, Christin E; Chi, Ping; Herlyn, Meenhard; Holmen, Sheri L; Karreth, Florian A; Kaufman, Charles K; Khan, Shaheen; Kobold, Sebastian; Leucci, Eleonora; Levy, Carmit; Lombard, David B; Lund, Amanda W; Marie, Kerrie L; Marine, Jean-Christophe; Marais, Richard; McMahon, Martin; Robles-Espinoza, Carla Daniela; Ronai, Ze'ev A; Samuels, Yardena; Soengas, Maria S; Villanueva, Jessie; Weeraratna, Ashani T; White, Richard M; Yeh, Iwei; Zhu, Jiyue; Zon, Leonard I; Hurlbert, Marc S; Merlino, Glenn.
Afiliação
  • Patton EE; MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: e.patton@igmm.ed.ac.uk.
  • Mueller KL; Melanoma Research Alliance, 730 15th Street NW, Washington, DC 20005, USA. Electronic address: kmueller@curemelanoma.org.
  • Adams DJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
  • Anandasabapathy N; Department of Dermatology, Meyer Cancer Center, Program in Immunology and Microbial Pathogenesis, Weill Cornell Medicine, New York, NY 10026, USA.
  • Aplin AE; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Bertolotto C; Université Côte d'Azur, Nice, France; INSERM, Biology and Pathologies of Melanocytes, Team 1, Equipe Labellisée Ligue 2020, Centre Méditerranéen de Médecine Moléculaire, Nice, France.
  • Bosenberg M; Departments of Dermatology, Pathology, and Immunobiology, Yale University, New Haven, CT, USA.
  • Ceol CJ; Program in Molecular Medicine and Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Burd CE; Departments of Molecular Genetics, Cancer Biology, and Genetics, The Ohio State University, Biomedical Research Tower, Room 918, 460 W. 12th Avenue, Columbus, OH 43210, USA.
  • Chi P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Wei
  • Herlyn M; The Wistar Institute, Philadelphia, PA, USA.
  • Holmen SL; Department of Surgery, University of Utah Health Sciences Center, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
  • Karreth FA; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Kaufman CK; Washington University School of Medicine, Department of Medicine, Division of Oncology, Department of Developmental Biology, McDonnell Science Building, 4518 McKinley Avenue, St. Louis, MO 63110, USA.
  • Khan S; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Member of the German Center for Lung Research (DZL), German Center for Translational Cancer Research (DKTK), partner site Mun
  • Leucci E; Laboratory for RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, 3000 Leuven, Belgium; Trace, Department of Oncology, LKI, KU Leuven, 3000 Leuven, Belgium.
  • Levy C; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Lombard DB; Department of Pathology, Institute of Gerontology, and Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
  • Lund AW; Ronald O. Perelman Department of Dermatology and Department of Pathology, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Marie KL; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Marine JC; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Marais R; CRUK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield SK10 4TG, UK.
  • McMahon M; Department of Dermatology & Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Robles-Espinoza CD; Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Campus Juriquilla, Boulevard Juriquilla 3001, Santiago de Querétaro 76230, Mexico; Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Ronai ZA; Cancer Center, Sanford Burnham Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Soengas MS; Spanish National Cancer Research Centre, 28029 Madrid, Spain.
  • Villanueva J; The Wistar Institute, Molecular and Cellular Oncogenesis Program, Philadelphia, PA, USA.
  • Weeraratna AT; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, and Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • White RM; Department of Cancer Biology & Genetics and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yeh I; Departments of Dermatology and Pathology, University of California, San Francisco, CA, USA.
  • Zhu J; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.
  • Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA.
  • Hurlbert MS; Melanoma Research Alliance, 730 15th Street NW, Washington, DC 20005, USA.
  • Merlino G; Center for Cancer Research, NCI, NIH, 37 Convent Drive, Bethesda, MD 20892, USA. Electronic address: gmerlino@helix.nih.gov.
Cancer Cell ; 39(5): 610-631, 2021 05 10.
Article em En | MEDLINE | ID: mdl-33545064
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Modelos Animais de Doenças / Microambiente Tumoral / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Modelos Animais de Doenças / Microambiente Tumoral / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article